These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7920997)

  • 1. New challenges in the growth field.
    DeVile CJ; Albanese A; Thomas B; Stanhope R
    J Pediatr Endocrinol; 1993; 6(3-4):295-301. PubMed ID: 7920997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
    Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the value of growth hormone treatment in short children with specified syndrome? Turner's syndrome, osteochondrodysplasias, Prader-Willi syndrome, Noonan syndrome.
    Nilsson KO
    Acta Paediatr Scand Suppl; 1989; 362():61-8. PubMed ID: 2485602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of final body heights in patients treated with growth hormone (somatotropin deficiency and Turner syndrome)].
    Rochiccioli P; Tauber MT
    Arch Pediatr; 1996; 3 Suppl 1():154s-155s. PubMed ID: 8795999
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
    Gault EJ; Perry RJ; Cole TJ; Casey S; Paterson WF; Hindmarsh PC; Betts P; Dunger DB; Donaldson MD;
    BMJ; 2011 Apr; 342():d1980. PubMed ID: 21493672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.
    Kappelgaard AM; Laursen T
    Growth Horm IGF Res; 2011 Dec; 21(6):305-13. PubMed ID: 22019012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of short stature and delayed adolescence.
    Wilson DM; Rosenfeld RG
    Pediatr Clin North Am; 1987 Aug; 34(4):865-79. PubMed ID: 3302896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy for syndromic disorders.
    Kelnar CJ
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):12-21. PubMed ID: 12807497
    [No Abstract]   [Full Text] [Related]  

  • 9. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
    Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
    Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth hormone for Turner's syndrome].
    Fishman A; Hochberg Z
    Harefuah; 1991 Nov; 121(9):281-6. PubMed ID: 1800273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-conventional use of growth hormone: European experience.
    Darendeliler F; Hindmarsh PC; Brook CG
    Horm Res; 1990; 33(2-4):128-36. PubMed ID: 2210617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to growth hormone treatment and final height after cranial or craniospinal irradiation.
    Sulmont V; Brauner R; Fontoura M; Rappaport R
    Acta Paediatr Scand; 1990 May; 79(5):542-9. PubMed ID: 2386044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Growth hormone therapy].
    Krysiak R; Okopień B; Gdula-Dymek A
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone treatment in Noonan syndrome.
    Tanaka T
    Acta Paediatr Jpn; 1996 Feb; 38(1):99-101. PubMed ID: 8992871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests.
    Massa G; Vanderschueren-Lodeweyckx M; Craen M; Vandeweghe M; van Vliet G
    Eur J Pediatr; 1991 May; 150(7):460-3. PubMed ID: 1915494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.